FDA Guidance for Industry: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
Title:
FDA Guidance for Industry: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
Origin/Publisher:
FDA
Content:
This guidance outlines FDA’s current thinking on several topics relevant to clinical research related to the development of drugs containing cannabis or cannabis-derived compounds